Introduction

Mar 4, 2017 by in PHARMACY Comments Off on Introduction

Introduction Subpart D2 of the Code of Federal Regulations is dedicated to equipment. 21 CFR 211.63 deals with design issues, 211.65 with construction, 211.67 and 68 deal with maintenance, cleaning,…

read more

Notes

Mar 4, 2017 by in PHARMACY Comments Off on Notes

1Pharmaceutical CGMPs for the 21st Century–A Risk-Based Approach Final Report; FDA, Sep. 2004. 2Guidance for Industry; Q 10 Pharmaceutical Quality Systems Q10, FDA, Apr. 2009 ICH. 3Guide to the Inspection…

read more

Risk Approach

Mar 4, 2017 by in PHARMACY Comments Off on Risk Approach

Basic Risk Approach4 A risk-based program needs to be established at the very beginning of the process validation program. Some criteria to be included in this risk program are: • Documentation…

read more

Programs

Mar 4, 2017 by in PHARMACY Comments Off on Programs

Quality Programs The Quality Program approach should be used for all CGMP activities. The FDA and the ICH have guidelines1,2 regarding this approach (see Appendix C). The Quality Programs are…

read more

Operating Procedures (SOPs) Preparation

Mar 4, 2017 by in PHARMACY Comments Off on Operating Procedures (SOPs) Preparation

Standard Operating Procedures (SOPs) Preparation In the preparation of SOPs there are often higher levels of documents that control the functionality of the various systems and operations. At a corporate…

read more

Started (After the Equipment Specifications)

Mar 4, 2017 by in PHARMACY Comments Off on Started (After the Equipment Specifications)

Getting Started (After the Equipment Specifications) Process validation cannot begin when the first commercial size batch is produced. It must start much earlier. In reality, process validation begins in the…

read more
Get Clinical Tree app for offline access